ÂÜÀòÂÒÂ×

Pamela M. Klein is an advisor at Shasqi and a former oncologist who has worked extensively in the biotech and pharmaceutical industries. Pamela has served as chief medical officer for several companies, including Intellikine Inc, where they helped bring multiple compounds into clinical trials, and Patrys Limited. Klein has also been a member of the board of directors for Spring Bank Pharmaceuticals, Inc. and the scientific advisory board for EOC Pharma/Eddingpharm. In their current role at Shasqi, Klein is responsible for advising the company on drug development strategy.

Pamela M. Klein has a M.D. from Loyola University Chicago Stritch School of Medicine in Oncology and Internal Medicine and a Bachelor's degree from California State University, Northridge in Biology and General.